Treatment of Vitamin B12 Deficiency
Initiate intramuscular hydroxocobalamin 1 mg immediately in all cases of vitamin B12 deficiency, with the specific regimen determined by the presence or absence of neurological symptoms. 1
Critical Pre-Treatment Assessment
Before starting therapy, screen every patient for neurological manifestations including:
- Pins-and-needles or numbness (paraesthesia) 2
- Balance problems and falls from impaired proprioception 2
- Gait disturbances and sensory ataxia 2, 1
- Visual disturbances related to optic nerve dysfunction (blurred vision, optic atrophy, visual field loss) 2, 1
- Cognitive difficulties such as "brain fog" or memory loss 2
Immediate Treatment Imperatives
Never administer folic acid before correcting vitamin B12 deficiency, as this can mask the deficiency and precipitate subacute combined degeneration of the spinal cord. 2, 1
Do not delay treatment while awaiting specialist consultation—begin intramuscular hydroxocobalamin immediately when neurological symptoms are present. 1
Treatment Regimens Based on Neurological Involvement
With Neurological Involvement
- Administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further clinical improvement is observed (duration is not fixed and may extend weeks to months). 2, 1
- Obtain urgent consultation from both a neurologist and haematologist. 2, 1
- After the loading phase, continue with hydroxocobalamin 1 mg intramuscularly every 2 months for life. 2
Without Neurological Involvement
- Administer hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks. 2
- Follow with maintenance treatment of 1 mg intramuscularly every 2-3 months for life. 2
Long-Term Maintenance Considerations
Maintain lifelong intramuscular hydroxocobalamin therapy regardless of symptom resolution; individualize the injection schedule based on recurrence of symptoms rather than laboratory values alone. 1, 3
Clinical experience indicates that up to 50% of patients require more frequent administration than standard guidelines suggest—ranging from daily, twice weekly, or every 2-4 weeks—to remain symptom-free. 3 Do not "titrate" injection frequency based on serum B12 or methylmalonic acid measurements. 3
Alternative Routes for Specific Situations
Oral High-Dose Therapy
For patients without severe neurological manifestations and with confirmed adherence capability, oral vitamin B12 at 1000 μg (1 mg) daily is an effective alternative to intramuscular therapy. 4, 5, 6
This approach:
- Normalizes serum B12 levels comparably to intramuscular administration 4
- Avoids injection-related discomfort and contraindications in anticoagulated patients 4
- Should not replace intramuscular therapy in patients with severe neurological symptoms 4
Sublingual preparations at similar doses have shown superiority to intramuscular administration in some studies, with mean increases in serum B12 of 252 ng/L versus 218 ng/L for intramuscular injections. 7
Common Pitfalls to Avoid
The most critical error is administering folic acid before treating B12 deficiency, which can precipitate irreversible spinal cord damage. 2, 1 Always check and correct B12 deficiency first when treating macrocytic anemia. 2
Do not postpone treatment in neurologically symptomatic patients while awaiting diagnostic confirmation or specialist input—immediate intramuscular therapy is essential to prevent irreversible neurological damage. 1
Avoid relying solely on laboratory values for maintenance dosing adjustments; clinical symptom recurrence should guide injection frequency. 1, 3
Special Population Considerations
Post-Bariatric Surgery Patients
These patients require lifelong intramuscular maintenance therapy every 2-3 months after initial correction, as malabsorption persists indefinitely. 2
Pregnancy and Breastfeeding
When iron treatment fails during pregnancy or breastfeeding, suspect and treat B12 deficiency promptly, as symptoms may be attributed to anemia alone. 2